{"version":"1.0","type":"link","title":"Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study.","author_name":"Celsa C 외","author_url":"https://prs-insight.online/author/Celsa%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/108642","thumbnail_width":1200,"thumbnail_height":630}